selected scholarly activity
-
conferences
- DISTRIBUTION AND CLINICAL IMPACT OF CLONAL PSEUDOMONAS AERUGINOSA INFECTION IN THE CANADIAN CYSTIC FIBROSIS POPULATION. Pediatric Pulmonology. S339-S339. 2017
- PREDICTORS OF RESPONSE TO ANTIBIOTIC TREATMENT OF PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS. Pediatric Pulmonology. 355-355. 2014
- RANDOMIZED CONTROLLED TRIAL OF BIOFILM ANTIMICROBIAL SUSCEPTIBILITY TESTING IN PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC PSEUDOMONAS AERUGINOSA INFECTION. Pediatric Pulmonology. 319-319. 2014
- Relationship Between Exacerbation Frequency And Clinical Outcomes In Patients With Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 2011
- TRANSLATING RESEARCH INTO PRACTICE: IMPLEMENTING A DECISION AID FOR ADULT CYSTIC FIBROSIS PATIENTS. Pediatric Pulmonology. 427-427. 2011
- Tissue Repair In Cystic Fibrosis Lung Disease. American Journal of Respiratory and Critical Care Medicine. 2011
- Central Statistical Monitoring Of An International Thromboprophylaxis Trial. American Journal of Respiratory and Critical Care Medicine. 2010
- A Multicentre Pilot Randomized Trial of High Frequency Oscillation in Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 2009
- Air Filtration for Childhood Asthma: A Pilot Randomized Trial. American Journal of Respiratory and Critical Care Medicine. 2009
- Current High Frequency Oscillation (HFO) Utilization in Ontario.. American Journal of Respiratory and Critical Care Medicine. 2009
- Validation of the Asthma Control Questionnaire in Children.. American Journal of Respiratory and Critical Care Medicine. 2009
- CFOS trial: Alendronate once weekly for the prevention and treatment of osteoporosis in Canadian adult cystic fibrosis patients. Journal of Bone and Mineral Research. S452-S452. 2007
- Alendronate once weekly for the prevention and treatment of osteoporosis in Canadian adult cystic fibrosis patients.. Journal of Bone and Mineral Research. S416-S416. 2006
- PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT): A Pilot Study.. Blood. 1784-1784. 2004
- High prevalence of fracture in young adults with cystic fibrosis.. Journal of Bone and Mineral Research. S294-S294. 2004
- Reliability study of APACHE II scores in a msICU. Critical Care Medicine. A68-A68. 2003
-
journal articles
- Reply to “Be smart in choosing antihistamines”. Journal of Allergy and Clinical Immunology: In Practice. 11:1332-1333. 2023
- The added value of haemoglobin to height, age, and sex to predict DLCO in subjects with preserved exercise capacity. PLoS ONE. 18:e0289540-e0289540. 2023
- Peanut Oral Immunotherapy With or Without H1 and H2 Antihistamine Premedication for Peanut Allergy (PISCES): A Placebo-Controlled Randomized Clinical Trial. Journal of Allergy and Clinical Immunology: In Practice. 10:2386-2394. 2022
- Exercise-induced bronchoconstriction and bronchodilation: investigating the effects of age, sex, airflow limitation and FEV1. European Respiratory Journal. 58:2004026-2004026. 2021
- The Impact of beta blockade on the cardio-respiratory system and symptoms during exercise. Current Research in Physiology. 4:235-242. 2021
- Epidemiology of Clonal Pseudomonas aeruginosa Infection in a Canadian Cystic Fibrosis Population. Annals of the American Thoracic Society. 15:827-836. 2018
- Prediction of clinical peanut allergy status among children in Hamilton, Ontario using chart review data collected during 2012–2015. Allergy, Asthma and Clinical Immunology. 13:10. 2017
- The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia. Research and Practice in Thrombosis and Haemostasis. 1:103-111. 2017
- Cystic fibrosis: past, present, future. Dr. Andreas Freitag in an interview with Dr. Roman Jaeschke. Polskie Archiwum Medycyny Wewnetrznej. 127:73-75. 2017
- Erratum to: Risk factors for mortality in patients admitted to intensive care units with pneumonia. Respiratory Research. 17:128. 2016
- Risk factors for and prediction of mortality in critically ill medical–surgical patients receiving heparin thromboprophylaxis. Annals of Intensive Care. 6:18. 2016
- Risk factors for mortality in patients admitted to intensive care units with pneumonia. Respiratory Research. 17:80. 2016
- The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness. Critical Care. 20:75. 2016
- Implementation of a cystic fibrosis lung transplant referral patient decision aid in routine clinical practice: an observational study. Implementation Science. 10:17. 2015
- Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients. Journal of Cystic Fibrosis. 14:755-762. 2015
- Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients. Journal of Cystic Fibrosis. 14:262-266. 2015
- New data on noninvasive ventilation in stable chronic obstructive pulmonary disease: revolutionary or evolutionary?. Polskie Archiwum Medycyny Wewnetrznej. 125:5-7. 2015
- Heparin-induced thrombocytopenia in the critically ill: Interpreting the 4Ts test in a randomized trial. Journal of Critical Care. 29:470.e7-470.e15. 2014
- Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis. Intensive Care Medicine. 39:2115-2125. 2013
- Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis. Chest. 144:1207-1215. 2013
- Complications From Recruitment Maneuvers in Patients With Acute Lung Injury: Secondary Analysis From the Lung Open Ventilation Study. Respiratory Care. 57:1842-1849. 2012
- Treatment of Aspergillus fumigatus in Patients with Cystic Fibrosis: A Randomized, Placebo-Controlled Pilot Study. PLoS ONE. 7:e36077-e36077. 2012
- High-frequency oscillation in adults: A utilization review*. Critical Care Medicine. 39:2631-2644. 2011
- Infection With Transmissible Strains of Pseudomonas aeruginosa and Clinical Outcomes in Adults With Cystic Fibrosis. Journal of the American Medical Association (JAMA). 304:2145-2145. 2010
- Randomized Trial of a Decision Aid for Patients with Cystic Fibrosis Considering Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 180:761-768. 2009
- Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients. BMC Musculoskeletal Disorders. 9:125. 2008
- Alendronate Once Weekly for the Prevention and Treatment of Bone Loss in Canadian Adult Cystic Fibrosis Patients (CFOS Trial). Chest. 134:794-800. 2008
- Prophylaxis Against Deep Vein Thrombosis in Critically Ill Patients With Severe Renal Insufficiency With the Low-Molecular-Weight Heparin Dalteparin<subtitle>An Assessment of Safety and Pharmacodynamics: The DIRECT Study</subtitle>. JAMA Internal Medicine. 168:1805-1805. 2008
- Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin prophylaxis: prevalence, incidence and risk factors. Critical Care. 12:R32-R32. 2008
- The Efficiency of Sputum Cell Counts in Cystic Fibrosis. Canadian Respiratory Journal. 14:99-103. 2007
- Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. Thorax. 61:969-974. 2006
- Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study. Journal of Critical Care. 20:364-372. 2005
- Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial. The Lancet. 366:463-471. 2005
- Glycemic control in the ICU: a multicenter survey. Intensive Care Medicine. 30:798-803. 2004
- Osteoporosis in Canadian adult cystic fibrosis patients: A descriptive study. BMC Musculoskeletal Disorders. 4:13. 2003
- Withdrawal of Mechanical Ventilation in Anticipation of Death in the Intensive Care Unit. New England Journal of Medicine. 349:1123-1132. 2003
- α1-Antitrypsin Deficiency Alleles in Cystic Fibrosis Lung Disease. American Journal of Respiratory Cell and Molecular Biology. 29:390-396. 2003
- Uptake of18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?. European Respiratory Journal. 21:848-854. 2003
- Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses.. Thorax. 48:594-598. 1993
- Changes in the Cellular Profile of Induced Sputum after Allergen-induced Asthmatic Responses. American Journal of Respiratory and Critical Care Medicine. 145:1265-1269. 1992